Developing nations suffer acutely from health epidemics due to lack of resources to adequately combat these epidemics. Many of these epidemics are managed reasonable well in developed nations but with low socioeconomic levels and poor living conditions, coupled with weak health infrastructure, diseases such as enteric and diarrheal diseases and AIDS are still major killers […]
Read More
Over the last 10 years, South Korea has increasingly become a global clinical trial (CT) hub and has established itself as one of the leading CT destinations in the Asia region. In 2015, South Korea approved a total of 675 trials from South Korean and multinational drug makers for early phase studies that would lead […]
Read More
New initiatives from the country’s regulator aim to smooth the registration of trials and ensure prospective participants fully understand what will be involved through mandatory AV recording of the consent process. Clinical trial applications in India are taking a step forward, with the approval of a Central Drugs Standard Control Organisation (CDSCO) IT-enabled system from […]
Read More
Do you ever wonder how prescription medications make their way to your local pharmacy? Clinical trials and health research play a vital role in maintaining the world population’s health on a regular basis. Without the proper research and clinical trials, many patients would still be suffering from ailments that are easily cured with medications now. […]
Read More
Effective 2nd August 2016, the Central Drugs Standard Control Organization (CDSCO) India released new circulars in relation to the conduct of clinical trials. These new circulars have modified the trial requirements for sponsors wishing to conduct clinical trials in India. Furthermore, the CDSCO have addressed matters that may assist in reducing clinical trial timelines and […]
Read More
The rising presence of clinical trials (CT) in the Asia-Pacific region is predominantly driven by the East Asian region which includes China, Japan, Korea, Taiwan and Hong Kong. Over the past decade, Korea has become a global clinical trial hub and is one of the leading clinical trial destinations in the Asian region; with approximately […]
Read More
In Australia, The Therapeutic Goods Administration (TGA) is responsible for the regulation of therapeutic goods (TG) – including medicines, vaccines, medical devices, in-vitro diagnostics and biologicals. They provide oversight over manufacturing, import and export of therapeutic goods, clinical trials (CT) and regulatory approvals processes. Australia is well known for its efficient CT start up timelines; […]
Read More
On a global scale, rotavirus causes over 500,000 deaths in children per year, particularly in emerging countries. Rotavirus is a contagious virus that can cause inflammation of the stomach and intestines – also identified as gastroenteritis. India has predicted that almost every child would experience an episode of rotavirus gastroenteritis by the age of 5. […]
Read More
Access to large markets where clinical trials that can investigate real patient needs, and do so in a rapid fashion, is invaluable for clinical research organisations. One such example of George Clinical rapid and access to huge markets took place in China, where diabetes patients numbered up to 90 million in 2010, and the most […]
Read More
